AliveCor unveiled the first medical-grade EKG band for the Apple Watch called Kardia Band. Pending FDA’s 510k clearance, the device along with a companion app — which is already available for download — allows people to discretely capture their EKG anytime, anywhere.
In order to get started with the Kardia Band, users simply touch the device’s integrated sensor that communicates with the Watch app, and get immediate results. The Atrial Fibrillation (AF) Detector uses Kardia’s algorithm to detect the presence of AF in an EKG, the most common cardiac arrhythmia and a leading cause of stroke. Also included is the Normal Detector that indicates whether user’s heart rate and rhythm are normal; and the Unreadable Detector, which tells users when to retake an EKG so physicians receive only the highest quality recordings.
Kardia Band is expected to be available in late spring.In addition to EKG, the app also allows users to record voice memos on their Apple Watch to accompany each EKG that give doctors and caregivers a clearer picture of what was happening at the time of the recording. Furthermore, Kardia integrates with Apple’s HealthKit to include EKG data along with steps and calorie intake to provide richer analysis over time.
“Kardia Band for Apple Watch represents both the future of proactive heart health and the introduction of the Wearable MedTech category,” Vic Gundotra, CEO of AliveCor, said in a statement. “These combined technologies give us the ability to deliver personal reports that provide analysis, insights and actionable advice for the patient and their doctor.”
Kardia Band provides caregivers the opportunity to take a more active role in helping their loved ones engage in their own care. The device is expected to be available in late spring.
In the other AliveCor news, the company is rebranding its AliveCor Mobile ECG to Kardia Mobile. With the new name, AliveCor aims to make Kardia synonymous with proactive heart health.